Why Oakridge International (ASX:OAK) Is Selling Nurse Call Technology to Care Providers After a Small FY2026 Profit

Sonal Goyal

19 October 2026 10:59 PM AEDT

Why Oakridge International (ASX:OAK) Is Selling Nurse Call Technology to Care Providers After a Small FY2026 Profit

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Why the nurse call story matters

Oakridge International Limited (ASX:OAK) is a small health technology company whose latest filings point to a Business that has moved from loss to a modest profit while still relying on a handful of contracts and a controlling shareholder. According to its FY2026 statutory accounts, released to the ASX on 24 August 2026, Revenue and other income rose about 42 per cent to $3.45 million and the company recorded a profit after tax of $109,171, against a loss of $128,795 a year earlier.

What the company does

Oakridge develops nurse call and Assistive Technology hardware and software for hospitals, aged care, disability care and supported independent living, according to its 31 July 2026 quarterly report. Recent work includes installations, nurse call upgrades, wireless solutions and real-time location system implementations. Product development covers enterprise reporting, annunciator firmware, a mobile app and single sign-on.

Latest verified developments

Customer cash receipts were $770,000 in the June 2026 quarter and $2.962 million for the 12 months to 30 June 2026, up from $2.458 million a year earlier, per the quarterly report. Management said channel activity, qualified opportunities and project conversions should support revenue growth through FY2027, and that a significant Volume of contracted work is awaiting invoicing and milestone delivery. That is company guidance and a statement about contracted work, not recognised revenue.

The company is also exploring adjacent technologies, including possible artificial intelligence applications for documentation and compliance, which it describes as early stage and subject to commercial evaluation.

Financial position and ownership

The FY2026 accounts show cash of $637,641, up from $468,939, net Assets of $1.36 million and total liabilities of $762,436. Shares on issue rose from 26,997,908 to 31,997,851 after Montague Capital Pty Ltd, an entity associated with director Con Unerkov, exercised 4,999,943 Options at $0.07, raising $349,996 net of costs. A substantial holder notice dated 4 August 2026 lists Montague at 52.81 per cent, with Teko International Limited at 9.77 per cent. There are 906,450 unlisted options outstanding at $0.10, expiring in late 2026, which could add modest dilution if exercised.

A modest cash balance should not on its own be read as distress.

Sector context and risks

Demand for care technology is supported, in the company's own words, by Australia's ageing population and aged-care workforce shortfall. Against that, sales cycles tied to hospital and aged-care capital budgets can be lumpy, and revenue depends on converting pipeline into delivered projects.

One specific risk is a legal matter. Oakridge completed a $250,000 share Placement with Teko International in January 2020. Teko raised a potential claim in 2020 alleging former directors misrepresented unrecorded liabilities. The board acknowledges potential exposure and is taking legal advice, according to the quarterly report. No outcome or quantified Liability was found in the sources read.

Upcoming dates

No confirmed catalysts have been announced by the company. An interim report is expected around 10 February 2027, though that date has not been confirmed by the company.

FAQs

Q: What were Oakridge International's (ASX:OAK) FY2026 results?

A: Oakridge International (ASX:OAK) reported revenue and other income up about 42 per cent to $3.45 million and a profit after tax of $109,171, against a loss of $128,795 a year earlier.

Q: What does Oakridge sell to care providers?

A: Oakridge develops nurse call and assistive technology hardware and software for hospitals, aged care, disability care and supported independent living. Recent work includes installations, nurse call upgrades, wireless solutions and real-time location system implementations.

Q: Who is Oakridge's largest shareholder?

A: A substantial holder notice dated 4 August 2026 lists Montague Capital Pty Ltd, an entity associated with director Con Unerkov, at 52.81 per cent. Teko International Limited holds 9.77 per cent.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.